6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
Just now	Appendix 4C and Quarterly Activities Report - March 2026
19m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
20m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
30m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

About

Heron Therapeuti (NASDAQ:HRTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Financials

Revenue

$154.9 M

Market Cap

$150.68 M

EPS

-0.12

Community Chat

Ask AI